(Q37604880)

21 August 2017

1 reference

title

Clinical approaches to early inflammatory arthritis (English)

1 reference

Dirkjan van Schaardenburg

21 August 2017

0 references

series ordinal

1

object named as

Dirkjan van Schaardenburg

1 reference

21 August 2017

Ben A C Dijkmans

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

29 September 2009

1 reference

Nature Reviews Rheumatology

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

627-633

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2009.203

21 August 2017

exact match

0 references

cites work

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Predictors of functional status in patients with early rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Imaging in rheumatoid arthritis--status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

The presence of citrullinated proteins is not specific for rheumatoid synovial tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc gamma RIIB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Elderly-onset rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

The influence of sex on the phenotype of rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: Results from the Norfolk Arthritis Register Study, a large inception cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

A review of the MHC genetics of rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Measurement of patient outcome in arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

A prediction rule for disease outcome in patients with Recent-onset undifferentiated arthritis: How to guide individual treatment decisions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Automated segmentation and quantification of inflammatory tissue of the hand in rheumatoid arthritis patients using magnetic resonance imaging data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Rheumatoid factor revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Immunity to citrullinated proteins in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Common variants at CD40 and other loci confer risk of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

TPMT testing in rheumatology: any better than routine monitoring?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Dealing with immunogenicity of biologicals: assessment and clinical relevance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Decrease of RA-related orthopaedic surgery of the upper limbs between 1998 and 2004: data from 54,579 Swedish RA inpatients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Tumor-induced osteomalacia: lessons learned

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

Factors predicting outcome of rheumatoid arthritis: results of a followup study

31 March 2020

1 reference

12 December 2020

Adverse effects of sulfasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene.

1 reference

12 December 2020

The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis.

1 reference

12 December 2020

Female gout. Clinical spectrum and uric acid metabolism

1 reference

12 December 2020

Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial

1 reference

12 December 2020

The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis

1 reference

12 December 2020

Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis

1 reference

12 December 2020

Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system

1 reference

12 December 2020

Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study.

1 reference

12 December 2020

Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage

1 reference

12 December 2020

Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification)

1 reference

12 December 2020

Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials.

1 reference

12 December 2020

The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients

1 reference

12 December 2020

A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools

1 reference

12 December 2020

The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association

1 reference

12 December 2020

Aspiration of normal or asymptomatic pathological joints for diagnosis and research: indications, technique and success rate

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.203

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NRRHEUM.2009.203

1 reference

21 August 2017

1 reference